Phillip Kim

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 14 EPO patents. Top assignees: Nestec S.a., Societe Des Produits Nestle S.a., Pierian Holdings, Inc.. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillip Kim. Retrieved from https://idiyas.com/inventor/phillip-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 5)

% Patents Active = 5.9

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 15)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 90(Granted Patents)

Company Filing History:

Societe Des Produits Nestle S.a.

patents

3 out of 3

Pierian Holdings, Inc.

patents

4. 1 out of 1

Diatech Holdings, Inc.

patent

5. 1 out of 22

Prometheus Laboratories Inc.

patents

Years Active: 2012-2020

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10697967 - Methods for predicting response of triple-negative breast cancer to therapy (2020-06-30),

2. 10640830 - Drug selection for non-small cell lung cancer therapy (2020-05-05),

3. 10527622 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2020-01-07),

4. 10473640 - Drug selection for gastric cancer therapy using antibody-based arrays (2019-11-12),

5. 10436786 - Methods for detecting truncated receptors using antibody-based arrays (2019-10-08),

6. 10401364 - Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling (2019-09-03),

7. 9903867 - Methods for predicting and improving the survival of colorectal cancer patients (2018-02-27),

8. 9726669 - Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy (2017-08-08),

9. 9719995 - Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling (2017-08-01),

10. 9664683 - Profiling of signal pathway proteins to determine therapeutic efficacy (2017-05-30),

11. 9575066 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2017-02-21),

12. 9488654 - Methods for predicting response of triple-negative breast cancer to therapy (2016-11-08),

13. 9285369 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2016-03-15),

14. 9274116 - Drug selection for breast cancer therapy using antibody-based arrays (2016-03-01),

15. 8658388 - Antibody-based arrays for detecting multiple signal transducers in rate circulating cells (2014-02-25),

Title: Inventor Phillip Kim - Pioneering Innovations in Irvine

Introduction: Phillip Kim is a renowned inventor based in Irvine, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Phillip Kim holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse expertise and innovative mindset.

Career Highlights: With over two decades of experience in the industry, Phillip Kim has successfully brought numerous inventions from concept to market, revolutionizing the way we interact with technology.

Collaborations: Throughout his career, Phillip Kim has collaborated with leading research institutions, universities, and tech companies to further advance his inventions and bring cutting-edge solutions to the market.

Conclusion: Phillip Kim's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.